Annual Interest Expense:
$1.57M+$1.48M(+1520.62%)Summary
- As of today, RXRX annual interest expense is $1.57 million, with the most recent change of +$1.48 million (+1520.62%) on December 31, 2024.
 - During the last 3 years, RXRX annual interest expense has fallen by -$1.38 million (-46.75%).
 - RXRX annual interest expense is now -46.75% below its all-time high of $2.95 million, reached on December 31, 2021.
 
Performance
RXRX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Interest Expense:
$480.00K-$28.00K(-5.51%)Summary
- As of today, RXRX quarterly interest expense is $480.00 thousand, with the most recent change of -$28.00 thousand (-5.51%) on June 30, 2025.
 - Over the past year, RXRX quarterly interest expense has increased by +$86.00 thousand (+21.83%).
 - RXRX quarterly interest expense is now -80.81% below its all-time high of $2.50 million, reached on June 30, 2021.
 
Performance
RXRX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Interest Expense:
$2.15M+$86.00K(+4.17%)Summary
- As of today, RXRX TTM interest expense is $2.15 million, with the most recent change of +$86.00 thousand (+4.17%) on June 30, 2025.
 - Over the past year, RXRX TTM interest expense has increased by +$1.68 million (+361.51%).
 - RXRX TTM interest expense is now -36.55% below its all-time high of $3.38 million, reached on June 30, 2021.
 
Performance
RXRX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
RXRX Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM | 
|---|---|---|---|
| 1Y1 Year | +1520.6% | +21.8% | +361.5% | 
| 3Y3 Years | -46.8% | +3328.6% | +837.1% | 
| 5Y5 Years | +147.6% | +12.7% | +90.3% | 
RXRX Interest Expense Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -46.8% | +2758.2% | -20.7% | +3592.3% | at high | +9654.5% | 
| 5Y | 5-Year | -46.8% | +2758.2% | -80.8% | +2626.3% | -36.5% | +9654.5% | 
| All-Time | All-Time | -46.8% | +2758.2% | -80.8% | +2626.3% | -36.5% | +9654.5% | 
RXRX Interest Expense History
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Jun 2025 | -  | $480.00K(-5.5%)  | $2.15M(+4.2%)  | 
| Mar 2025 | -  | $508.00K(-16.0%)  | $2.06M(+31.0%)  | 
| Dec 2024 | $1.57M(+1520.6%)  | $605.00K(+9.4%)  | $1.57M(+58.3%)  | 
| Sep 2024 | -  | $553.00K(+40.4%)  | $993.00K(+113.5%)  | 
| Jun 2024 | -  | $394.00K(+1870.0%)  | $465.00K(+379.4%)  | 
| Mar 2024 | -  | $20.00K(-23.1%)  | $97.00K(+1.0%)  | 
| Dec 2023 | $97.00K(+76.4%)  | $26.00K(+4.0%)  | $96.00K(+15.7%)  | 
| Sep 2023 | -  | $25.00K(-3.8%)  | $83.00K(+16.9%)  | 
| Jun 2023 | -  | $26.00K(+36.8%)  | $71.00K(+20.3%)  | 
| Mar 2023 | -  | $19.00K(+46.2%)  | $59.00K(+9.3%)  | 
| Dec 2022 | $55.00K  | $13.00K(0.0%)  | $54.00K(+145.5%)  | 
| Sep 2022 | -  | $13.00K(-7.1%)  | $22.00K(-90.4%)  | 
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Jun 2022 | -  | $14.00K(0.0%)  | $229.00K(-91.6%)  | 
| Mar 2022 | -  | $14.00K(+173.7%)  | $2.72M(-8.0%)  | 
| Dec 2021 | $2.95M(+117.1%)  | -$19.00K(-108.6%)  | $2.95M(-7.8%)  | 
| Sep 2021 | -  | $220.00K(-91.2%)  | $3.20M(-5.4%)  | 
| Jun 2021 | -  | $2.50M(+904.4%)  | $3.38M(+158.8%)  | 
| Mar 2021 | -  | $249.00K(+7.8%)  | $1.31M(-3.8%)  | 
| Dec 2020 | $1.36M(+114.2%)  | -  | -  | 
| Dec 2020 | -  | $231.00K(-42.4%)  | $1.36M(+20.5%)  | 
| Sep 2020 | -  | $401.00K(-5.9%)  | $1.13M(+55.2%)  | 
| Jun 2020 | -  | $426.00K(+41.5%)  | $727.00K(+141.5%)  | 
| Mar 2020 | -  | $301.00K  | $301.00K  | 
| Dec 2019 | $635.00K  | -  | -  | 
FAQ
- What is Recursion Pharmaceuticals, Inc. annual interest expense?
 - What is the all-time high annual interest expense for Recursion Pharmaceuticals, Inc.?
 - What is Recursion Pharmaceuticals, Inc. annual interest expense year-on-year change?
 - What is Recursion Pharmaceuticals, Inc. quarterly interest expense?
 - What is the all-time high quarterly interest expense for Recursion Pharmaceuticals, Inc.?
 - What is Recursion Pharmaceuticals, Inc. quarterly interest expense year-on-year change?
 - What is Recursion Pharmaceuticals, Inc. TTM interest expense?
 - What is the all-time high TTM interest expense for Recursion Pharmaceuticals, Inc.?
 - What is Recursion Pharmaceuticals, Inc. TTM interest expense year-on-year change?
 
What is Recursion Pharmaceuticals, Inc. annual interest expense?
The current annual interest expense of RXRX is $1.57M
What is the all-time high annual interest expense for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual interest expense is $2.95M
What is Recursion Pharmaceuticals, Inc. annual interest expense year-on-year change?
Over the past year, RXRX annual interest expense has changed by +$1.48M (+1520.62%)
What is Recursion Pharmaceuticals, Inc. quarterly interest expense?
The current quarterly interest expense of RXRX is $480.00K
What is the all-time high quarterly interest expense for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly interest expense is $2.50M
What is Recursion Pharmaceuticals, Inc. quarterly interest expense year-on-year change?
Over the past year, RXRX quarterly interest expense has changed by +$86.00K (+21.83%)
What is Recursion Pharmaceuticals, Inc. TTM interest expense?
The current TTM interest expense of RXRX is $2.15M
What is the all-time high TTM interest expense for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high TTM interest expense is $3.38M
What is Recursion Pharmaceuticals, Inc. TTM interest expense year-on-year change?
Over the past year, RXRX TTM interest expense has changed by +$1.68M (+361.51%)